{
    "Trade/Device Name(s)": [
        "Randox Liquid Immunoassay Premium Controls Level 1",
        "Randox Liquid Immunoassay Premium Controls Level 2",
        "Randox Liquid Immunoassay Premium Controls Level 3",
        "Randox Liquid Immunoassay Premium Controls Tri Level"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K112337",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "October 4, 2011",
    "Summary Letter Received Date": "October 6, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [],
    "Analyte(s)": [],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Liquid Immunoassay Premium Controls Level 1, 2, 3, and Tri Level as quality control materials for quantitative immunoassay procedures",
    "Indications for Use Summary": "Liquid controls for quality control of quantitative assays as stated in the product insert; intended for prescription use only",
    "fda_folder": "Clinical Chemistry"
}